Patient Rating:

No Rating Available?

John M. Hoffman, M.D.

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 587-4064 Huntsman Cancer Hospital
1950 Circle of Hope
Salt Lake City, UT 84112
Map
(801) 581-2370 University Hospital
Radiology
50 N Medical Dr
Salt Lake City, UT 84132
Map

Bio

John Hoffman, MD, is a professor of radiology and neurology and director of nuclear medicine in the Department of Radiology at the University of Utah. He is also director of the Molecular Imaging Program at Huntsman Cancer Institute and co-leader of the Experimental Therapeutics Program. He holds the Willard Snow Hansen Presidential Endowed Chair in Cancer Research.

Board Certification and Academic Information

Academic Departments Radiology - Professor
Neurology - Professor
Academic Divisions Clinical Radiology
Board Certification American Board of Nuclear Medicine (Nuc Med)
Cancer Center Programs Experimental Therapeutics

Academic Profile

Board Certification and Academic Information

Academic Departments Radiology - Professor
Neurology - Professor
Academic Divisions Clinical Radiology
Board Certification American Board of Nuclear Medicine (Nuc Med)
Cancer Center Programs Experimental Therapeutics

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 581-7553 Huntsman Cancer Institute
Radiology
2000 Circle of Hope
Salt Lake City, UT 84112

Academic Bio

John Hoffman, MD, is a professor of radiology and neurology and director of nuclear medicine in the Department of Radiology at the University of Utah. He is also director of the Molecular Imaging Program at Huntsman Cancer Institute and co-leader of the Experimental Therapeutics Program. He holds the Willard Snow Hansen Presidential Endowed Chair in Cancer Research. Dr. Hoffman's research interests include the use of PET imaging for cancer diagnosis and prognosis.

Education

Education History

Type School Degree
Fellowship UCLA Medical Center
Nuclear Medicine
Fellow
Residency University of Washington
Neurology
Resident
Residency University of Washington
Neurosurgery
Resident
Internship University of Washington
Surgery
Intern
Internship University of Wyoming, College of Human Medicine
Internship
Intern
Professional Medical University of Colorado School of Medicine
M.D.
Undergraduate University of Pennsylvania
Bioengineering
B.S.E.

Publications

Selected Provider Publications

Journal Article

  1. Single-scan dual-tracer FLT+FDG PET tumor characterization.Kadrmas DJ, Rust TC, Hoffman JM (2013). Single-scan dual-tracer FLT+FDG PET tumor characterization. Phys Med Biol, 58(3), 429-49.
  2. Amyloid deposition and cognition in older adults: the effects of premorbid intellect.Duff K, Foster NL, Dennett K, Hammers DB, Zollinger LV, Christian PE, Butterfield RI, Beardmore BE, Wang AY, Morton KA, Hoffman JM (2013). Amyloid deposition and cognition in older adults: the effects of premorbid intellect. Arch Clin Neuropsychol, 28(7), 665-71.
  3. A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism.Rondina MT, Wanner N, Pendleton RC, Kraiss LW, Vinik R, Zimmerman GA, Heilbrun M, Hoffman JM, Morton KA (2012). A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism. Thromb Res, 129(1), 22-7.
  4. Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma.Enslow MS, Zollinger LV, Morton KA, Butterfield RI, Kadrmas DJ, Christian PE, Boucher KM, Heilbrun ME, Jensen RL, Hoffman JM (2012). Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma. Clin Nucl Med, 37(9), 854-61.
  5. (18)F-FDG PET in the evaluation of acuity of deep vein thrombosis.Rondina MT, Lam UT, Pendleton RC, Kraiss LW, Wanner N, Zimmerman GA, Hoffman JM, Hanrahan C, Boucher K, Christian PE, Butterfield RI, Morton KA (2012). (18)F-FDG PET in the evaluation of acuity of deep vein thrombosis. Clin Nucl Med, 37(12), 1139-45.
  6. Bioimaging of copper alterations in the aging mouse brain by autoradiography, laser ablation inductively coupled plasma mass spectrometry and immunohistochemistry.Wang LM, Becker JS, Wu Q, Oliveira MF, Bozza FA, Schwager AL, Hoffman JM, Morton KA (2010). Bioimaging of copper alterations in the aging mouse brain by autoradiography, laser ablation inductively coupled plasma mass spectrometry and immunohistochemistry. Metallomics, 2(5), 348-53.
  7. Wu X, Jeong EK, Emerson L, Hoffman JM, Parker DL, Lu ZR (2010). Noninvasive evaluation of antiangiogenic effect in a mouse tumore model by DCE-MRI with Gd-DTPA cystamine copolymers. Mol Pharm, 7, 41-48.
  8. NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studies.Spence AM, Muzi M, Link JM, OSullivan F, Eary JF, Hoffman JM, Shankar LK, Krohn KA (2009). NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studies. Mol Imaging Biol, 11(5), 343-55.
  9. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR, Heilbrun M, Wiggins RH 3rd, Hunt JP, Bentz BG, Hitchcock YJ, Morton KA (2009). Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. J Nucl Med, 50(8), 1205-13.
  10. NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of FLT as a Marker of Proliferation in Patients with Recurrent Gliomas: Safety Studies.Spence AM, Muzi M, Link JM, Hoffman JM, Eary JF, Krohn KA (2008). NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of FLT as a Marker of Proliferation in Patients with Recurrent Gliomas: Safety Studies. Mol Imaging Biol, 10(5), 271-280.

Review

  1. Methodology for quantitative rapid multi-tracer PET tumor characterizations.Kadrmas DJ, Hoffman JM (2013). Methodology for quantitative rapid multi-tracer PET tumor characterizations. [Review]. Theranostics, 3(10), 757-73.

Clinical Trials

Video & News